Nimotuzumab Plus Gemcitabine for K-Ras Wild-Type Locally Advanced or Metastatic Pancreatic Cancer.

Shu-Kui QinJin LiYuxian BaiZishu WangZhendong Chen Rui-Hua Xu Jian-Ming Xu Hong-Mei ZhangJia ChenYing YuanTianshu LiuLin YangHaijun ZhongDonghui ChenLin ShenChunyi HaoDeliang FuYing ChengJianwei YangQiong WangBaoli QinHongming PanJun ZhangXianhong BaiQingshan Zheng

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)

In patients with locally advanced or metastatic K-Ras wild-type PC, nimotuzumab plus gemcitabine significantly improved OS and PFS with a good safety profile.

Keyphrases

wild type
locally advanced
squamous cell carcinoma
neoadjuvant chemotherapy
rectal cancer
phase ii study
radiation therapy
small cell lung cancer
clinical trial